BIOGEN INC (BIIB)
US09062X1037 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.29B | 3.42B | 2.26B | 1.33B | 2.91B | |||
| Marketable Securities | 0.00 | 1.47B | 1.54B | 1.28B | 1.56B | |||
| Receivables | 2.21B | 2.14B | 1.96B | 2.33B | 2.47B | |||
| Inventories | 2.98B | 1.34B | 1.35B | 1.07B | 804.00M | |||
| Other Current Assets | 974.00M | 1.42B | 741.00M | 881.00M | 631.00M | |||
| Total Current Assets | 8.45B | 9.79B | 7.86B | 6.89B | 8.38B | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.76B | 3.70B | 3.79B | 3.85B | 3.67B | |||
| Investments And Advances | 755.00M | 2.23B | 2.83B | 3.67B | 2.65B | |||
| Goodwill | 6.81B | 5.75B | 5.76B | 5.76B | 5.76B | |||
| Intangibles | 7.34B | 1.85B | 2.22B | 3.08B | 3.53B | |||
| Other Non-Current Assets | 1.07B | 1.23B | 1.42B | 1.37B | 3.24B | |||
| Total Non-Current Assets | 19.74B | 14.76B | 16.02B | 17.73B | 18.85B | |||
| TOTAL ASSETS | 28.19B | 24.55B | 23.88B | 24.62B | 27.23B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 500.00M | 0.00 | 999.00M | 0.00 | 1.50B | |||
| Accrued Expenses | 2.83B | 1.59B | 1.47B | 1.72B | 1.68B | |||
| Accounts Payable | 440.00M | 492.00M | 589.00M | 455.00M | 531.00M | |||
| Other Current Liabilities | 1.25B | 1.19B | 1.24B | 1.57B | 1.16B | |||
| Total Current Liabilities | 5.02B | 3.27B | 4.30B | 3.74B | 4.86B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.79B | 6.28B | 6.27B | 7.43B | 4.46B | |||
| Deferred Taxes/Income | 728.00M | 335.00M | 695.00M | 1.03B | 2.81B | |||
| Other Non-Current Liabilities | 1.18B | 1.28B | 1.65B | 1.73B | 1.76B | |||
| Total Non-Current Liabilities | 8.69B | 7.88B | 8.68B | 10.18B | 9.03B | |||
| TOTAL LIABILITIES | 13.71B | 11.16B | 12.98B | 13.92B | 13.89B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 17.38B | 16.47B | 13.91B | 13.98B | 16.45B | |||
| Additional Paid In Capital | 242.00M | 73.00M | 68.00M | 0.00 | 0.00 | |||
| Minority Interest | -3.80M | 75.00M | -108.00M | -74.00M | -4.00M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -2.98B | -2.98B | -2.98B | -2.98B | -2.98B | |||
| Other Shareholders' Equity | -159.00M | -149.00M | -105.00M | -300.00M | -139.00M | |||
| Shares Outstanding | 145.00M | 144.00M | 147.00M | 152.00M | 174.00M | |||
| Tangible Book Value per Share | 2.28 | 40.27 | 19.82 | 12.20 | 23.32 | |||
| Total Shareholders' Equity | 14.48B | 13.40B | 10.90B | 10.70B | 13.34B | |||
| TOTAL LIABILITIES AND EQUITY | 28.19B | 24.55B | 23.88B | 24.62B | 27.23B | |||
| Statistics | ||||||||
| Debt/Equity | 0.47 | 0.47 | 0.58 | 0.69 | 0.33 | |||
| Current Ratio | 1.68 | 2.99 | 1.83 | 1.84 | 1.72 | |||
| Return On Assets (ROA) | 5.18% | 12.41% | 6.52% | 16.25% | 21.62% | |||
| Return On Equity (ROE) | 10.09% | 22.74% | 14.28% | 37.39% | 44.14% | |||
| Return On Invested Capital (ROIC) | 9.35% | 13.58% | 16.01% | 21.37% | 30.30% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 10.38% | 17.64% | 19.86% | 24.42% | 37.87% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 32.20% | 32.89% | 40.20% | 47.35% | 78.72% | |||
All data in USD